About the Authors
- Jean Marie Cohen
-
* E-mail: jmcoco@openrome.org
Affiliations Open Rome (Organize and Promote Epidemiological Network), Paris, France, Réseau des GROG, Paris, France
- Maria Laura Silva
-
Affiliation Open Rome (Organize and Promote Epidemiological Network), Paris, France
- Saverio Caini
-
Affiliation Open Rome (Organize and Promote Epidemiological Network), Paris, France
- Meral Ciblak
-
Affiliation Istanbul University, Istanbul, Turkey
- Anne Mosnier
-
Affiliations Open Rome (Organize and Promote Epidemiological Network), Paris, France, Réseau des GROG, Paris, France
- Isabelle Daviaud
-
Affiliation Open Rome (Organize and Promote Epidemiological Network), Paris, France
- Gonçalo Matias
-
Affiliation GlaxoSmithKline (GSK) Biologicals, Brussels, Belgium
- Selim Badur
-
Affiliation Istanbul University, Istanbul, Turkey
- Martine Valette
-
Affiliation Virology Department, National Influenza Center, Claude Bernard University Lyon 1, Lyon, France
- Vincent Enouf
-
Affiliation Virology Department, Unit of Molecular Genetics of RNA viruses, National Influenza Center, Pasteur Institute, CNRS UMR3569, Université Paris Diderot Sorbonne Paris Cité, Paris, France
- John Paget
-
Affiliation Netherlands Institute for Health Services research (NIVEL), Utrecht, The Netherlands
- Douglas M. Fleming
-
Affiliation Royal College of General Practitioners, Surveillance and Research Unit, Birmingham, United Kingdom
- IBGP study team
-
¶Membership of the IBGP study team is listed in the Acknowledgments.
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: M.L.S., S.C., M.C., S.B., M.V. and V.E. declare having no conflicts of interest. J.M.C. and A.M. declare having received support for travel to meetings (Roche) and their institutions received grants from the study sponsor and from several pharmaceutical companies (Roche, AstraZeneca, Sanofi Pasteur MSD, GSK, Mylan) on matters relating to influenza surveillance and to the burden of illness due to influenza and its prevention. I.D. declares her institutions received grants from the study sponsor and from several pharmaceutical companies (Roche, AstraZeneca, Sanofi Pasteur MSD, GSK, Mylan) on matters relating to influenza surveillance and to the burden of illness due to influenza and it's prevention. W.J.P. has served on an influenza advisory board for GSK. G.M. declares being employed by GlaxoSmithKline Vaccines which has financed the IBGP study. D.F. declares having received consultancy payments from Open Rome relating to the design analysis and reporting of this material and having provided advisory board consultancy services to several pharmaceutical companies on matters relating to the burden of illness due to influenza and its prevention. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JMC GM JP DMF. Performed the experiments: JMC MLS MC AM ID MV VE. Analyzed the data: JMC MLS AM ID. Contributed reagents/materials/analysis tools: MV VE MC SB. Wrote the paper: JMC SC AM ID JP DMF.